Polycythaemia
Results
Phase 3
This trial compared ruxolitinib with hydroxycarbamide (hydroxyurea) to see which was better at treating symptoms of polycythaemia vera (PV).
Recruitment start: 28 August 2012
Recruitment end: 15 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Yasmin Hasan
Experimental Cancer Medicine Centre (ECMC)
Incyte Corporation
NIHR Clinical Research Network: Cancer
Last reviewed: 10 May 2017
CRUK internal database number: 10641
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
